The first participant has been dosed in Regimen I of the HEALEY ALS Platform Trial evaluating Neurizon Therapeutics’ lead candidate ... Read More The post First participant dosed with Neurizon’s lead drug candidate in landmark HEALEY ALS trial appeared first on Stockhead .